These observations stress the importance of novel and personalized therapeutic interventions for cancer patients carrying mutant TP53 gene in order to uncover new molecular targets to prevent the GOF mutant p53-driven alterations on cancer energy metabolism, which sustains tumor progression. Here, TP53 is linked to neoplasm.